ZBH Logo

Zimmer Biomet Holdings, Inc. (ZBH) 

NYSE
Market Cap
$21.57B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
397 of 774
Rank in Industry
52 of 99

Largest Insider Buys in Sector

ZBH Stock Price History Chart

ZBH Stock Performance

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate …

Insider Activity of Zimmer Biomet Holdings, Inc.

Over the last 12 months, insiders at Zimmer Biomet Holdings, Inc. have bought $0 and sold $5.06M worth of Zimmer Biomet Holdings, Inc. stock.

On average, over the past 5 years, insiders at Zimmer Biomet Holdings, Inc. have bought $485,817 and sold $4.92M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,135 shares for transaction amount of $223,641 was made by Jafry Syed A. (director) on 2023‑11‑09.

List of Insider Buy and Sell Transactions, Zimmer Biomet Holdings, Inc.

2024-05-31SaleGroup President, Asia Pacific
12,857
0.0062%
$114.69$1.47M-6.14%
2024-03-07SaleGroup President, Asia Pacific
1,705
0.0008%
$126.86$216,296-11.48%
2024-02-22SaleSr. VP/Gen Counsel/Secretary
26,156
0.0125%
$128.62$3.36M-11.76%
2023-11-09Purchasedirector
2,135
0.001%
$104.75$223,641+12.82%
2023-08-30Purchasedirector
1,000
0.0005%
$120.37$120,370-0.84%
2023-08-28Purchasedirector
2,000
0.0009%
$116.48$232,960+1.54%
2023-08-28Purchasedirector
1,000
0.0005%
$117.11$117,114+1.54%
2023-08-25Purchasedirector
871
0.0004%
$114.84$100,023+3.59%
2023-08-25Purchasedirector
1,300
0.0006%
$115.50$150,150+3.59%
2023-08-23Purchasedirector
1,000
0.0005%
$115.61$115,613+3.91%
2023-03-17SaleSr. VP/Gen Counsel/Secretary
23,045
0.011%
$124.50$2.87M+0.40%
2022-12-13SaleSr. VP/Gen Counsel/Secretary
11,522
0.0055%
$128.63$1.48M-1.89%
2022-07-01SalePres, Europe, M. East & Africa
531
0.0002%
$105.22$55,870+15.99%
2022-03-17SaleSr. VP/Gen Counsel/Secretary
29,518
0.0141%
$121.90$3.6M-2.98%
2021-12-14SalePresident, Asia Pacific
5,600
0.0027%
$124.14$695,198-2.36%
2021-05-06Purchasedirector
2,000
0.0005%
$85.79$171,580-18.81%
2020-11-18SalePresident, Asia Pacific
2,400
0.0012%
$152.59$366,216+6.65%
2020-11-09SaleSr. VP/Gen Counsel/Secretary
60,080
0.0149%
$79.85$4.8M+1.34%
2020-05-29SalePresident, Asia Pacific
6,000
0.0029%
$125.38$752,260+17.84%
2020-05-13PurchasePresident and CEO
2,000
0.001%
$113.00$226,000+32.20%

Insider Historical Profitability

7.8%
Hanson Bryan CPresident and CEO
54568
0.0274%
$108.3660+5.73%
GLASSCOCK LARRY Cdirector
8593
0.0043%
$108.3614+11.99%
BERNARD BETSY Jdirector
5271
0.0026%
$108.3630+14.12%
HAGEMANN ROBERTdirector
4000
0.002%
$108.3620+13.96%
Jafry Syed A.director
4060
0.002%
$108.3620+9.03%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$3.14B11.5623.77M-0.36%-$11.41M0.06
BlackRock$2.28B8.417.28M-7.64%-$188.65M0.05
Dodge & Cox$2.17B7.9816.42M+43.09%+$652.61M1.26
T. Rowe Price$1.4B5.1710.64M+12.9%+$160.48M0.17
State Street$1.23B4.529.31M-0.06%-$752,719.910.05
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.